indomethacin has been researched along with Infant, Small for Gestational Age in 5 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When Indomethacin in a dosage of 175 mg/day was used to treat threatened premature labour more than 70% of cases carried on until 37 weeks." | 6.37 | [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients]. ( Barrat, J; Bouillie, J; Boyer, F; Keskes, J; Marpeau, L; Pigné, A; Vincenti, O, 1988) |
| "Optimal management of the patent ductus arteriosus (PDA) in preterm infants remains controversial." | 2.84 | Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants. ( Bell, EF; Bethany Ball, M; Boghossian, NS; Brumbaugh, JE; Dagle, JM; Das, A; Do, BT; Sanchez, PJ; Shankaran, S; Stoll, BJ; Vohr, BR; Wyckoff, MH, 2017) |
| "When Indomethacin in a dosage of 175 mg/day was used to treat threatened premature labour more than 70% of cases carried on until 37 weeks." | 2.37 | [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients]. ( Barrat, J; Bouillie, J; Boyer, F; Keskes, J; Marpeau, L; Pigné, A; Vincenti, O, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saxton, SN | 1 |
| Evered, J | 1 |
| McCoy, K | 1 |
| Atkins, K | 1 |
| Boghossian, NS | 1 |
| Do, BT | 1 |
| Bell, EF | 1 |
| Dagle, JM | 1 |
| Brumbaugh, JE | 1 |
| Stoll, BJ | 1 |
| Vohr, BR | 1 |
| Das, A | 1 |
| Shankaran, S | 1 |
| Sanchez, PJ | 1 |
| Wyckoff, MH | 1 |
| Bethany Ball, M | 1 |
| Müller, H | 1 |
| End, C | 1 |
| Weiss, C | 1 |
| Renner, M | 1 |
| Bhandiwad, A | 1 |
| Helmke, BM | 1 |
| Gassler, N | 1 |
| Hafner, M | 1 |
| Poustka, A | 1 |
| Mollenhauer, J | 1 |
| Poeschl, J | 1 |
| Burnard, ED | 1 |
| Thomas, DB | 1 |
| Grattan-Smith, P | 1 |
| Marpeau, L | 1 |
| Keskes, J | 1 |
| Vincenti, O | 1 |
| Boyer, F | 1 |
| Bouillie, J | 1 |
| Pigné, A | 1 |
| Barrat, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants[NCT00063063] | 80,000 participants (Anticipated) | Observational | 1987-01-31 | Recruiting | |||
| Follow-up Visit of High Risk Infants[NCT00009633] | 68,000 participants (Anticipated) | Observational | 1993-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indomethacin and Infant, Small for Gestational Age
| Article | Year |
|---|---|
[Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients].
Topics: Abortion, Threatened; Acute Kidney Injury; Ductus Arteriosus, Patent; Female; Fetal Death; Fetus; Hu | 1988 |
1 trial available for indomethacin and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indom | 2017 |
Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indom | 2017 |
Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indom | 2017 |
Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indom | 2017 |
3 other studies available for indomethacin and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Effects of a small-baby protocol on early and long-term outcomes in extremely preterm infants: A quality improvement study.
Topics: Cerebral Hemorrhage; Female; Humans; Indomethacin; Infant; Infant, Extremely Premature; Infant, Newb | 2023 |
Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection.
Topics: Biomarkers; Blotting, Western; Calcium-Binding Proteins; Communicable Diseases; DNA-Binding Proteins | 2008 |
Early indomethacin in patent ductus of the very small premature.
Topics: Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Infant, Premature, Diseases; Infan | 1982 |